Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 8.00
+0.22 (2.83%)
Last updated: Dec 30, 2025, 9:00 AM CET
Svas Biosana Market Cap
Svas Biosana has a market cap or net worth of €42.51 million as of January 2, 2026. Its market cap has increased by 15.80% in one year.
Market Cap
42.51M
Enterprise Value
87.44M
Revenue
134.95M
Ranking
n/a
PE Ratio
6.30
Stock Price
€8.00
Market Cap Chart
Since December 9, 2021, Svas Biosana's market cap has decreased from 81.14M to 42.51M, a decrease of -47.61%. That is a compound annual growth rate of -14.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 42.51M | 10.91% |
| Dec 30, 2024 | 38.33M | -11.25% |
| Dec 29, 2023 | 43.19M | -20.87% |
| Dec 30, 2022 | 54.58M | -37.13% |
| Dec 30, 2021 | 86.80M | 6.97% |
| Dec 9, 2021 | 81.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 9.92B |
| DiaSorin | 3.70B |
| Amplifon | 3.02B |
| EL.En. | 1.12B |
| Philogen | 938.16M |
| Safilo Group | 793.68M |
| Pharmanutra | 518.58M |
| Garofalo Health Care | 489.36M |